PUBLISHER: Mordor Intelligence | PRODUCT CODE: 2116677
PUBLISHER: Mordor Intelligence | PRODUCT CODE: 2116677
According to Mordor Intelligence, the India ultrasound devices market size was valued at USD 271.31 million in 2025 and estimated to grow from USD 285.98 million in 2026 to reach USD 372.08 million by 2031, at a CAGR of 5.41% during the forecast period (2026-2031).

This report is Segmented by Application (Anesthesiology, Cardiology, Gynecology/Obstetrics, and More), Technology (2D Ultrasound Imaging, and More), Portability (Stationary Systems, and More), End User (Hospitals, and More), and Region (North India, South India, West India, East India, Central India, North-East India). The Market Forecasts are Provided in Terms of Value (USD) and Volume (Units).
One in four Indian adults screened at Apollo Hospitals in 2025 was hypertensive, and nearly the same proportion was diabetic, underscoring a silent epidemic that propels ultrasound from episodic diagnostic use to routine community screening. NPCDCS clinics now operate across every state, embedding ultrasound into standardized protocols at primary centers. Preventive-care financing under Ayushman Bharat further embeds structured reimbursement, while AIIMS Delhi's oncology AI, trained on 500,000 images, exemplifies how artificial intelligence augments image interpretation and mitigates workforce gaps. The combined effect is sustained volume growth for portable units that reach urban outreach camps and rural wellness centers.
The eSanjeevani tele-consult platform has served 340 million patients since 2021, integrating imaging referrals into virtual primary care and stimulating demand for systems that upload scans directly to cloud archives. Aster CMI Hospital's 95%-accurate carpal-tunnel AI illustrates specialized ultrasound expansion beyond obstetrics. Hyderabad's SMART DROP diabetic-retinopathy protocol proves how structured screening cascades into higher equipment utilization inside diabetes clinics. Ayushman Bharat reimbursement removes price friction, letting facilities deploy midrange scanners without delaying ROI, thereby accelerating the India ultrasound devices market.
CDSCO halted refurbished high-end imports in April 2024, citing safety, and its protracted MD-15 approvals encouraged several OEMs to divert assembly to Vietnam, delaying product refresh cycles in India. Although the National Single Window System aims to compress review times, compliance costs remain steep for start-ups. The 2024 marketing code further limits aggressive promotion but promises higher buyer trust long term.
Other drivers and restraints analyzed in the detailed report include:
For complete list of drivers and restraints, kindly check the Table Of Contents.
Radiology anchored a 37.31% India ultrasound devices market share in 2025 as tertiary hospitals conducted comprehensive abdominal, obstetric, and vascular exams in centralized imaging suites. Critical Care posted the highest 3.75% CAGR, propelled by trauma protocols requiring bedside echo within 5 minutes of admission and by the India ultrasound devices market size growth inside emergency departments. Portable probes allied with AI decision support amplify throughput in ICU rounds and cardiac arrest calls. Gynecology/Obstetrics sustains double-digit volume as maternal-mortality reduction remains a policy target, whereas Musculoskeletal imaging gains visibility through sports-injury clinics that value quick tendon assessments.
Cardiology extends share through AI-enabled speckle-tracking that standardizes ejection-fraction calculation, and Urology leverages ultrasound guidance for minimally invasive stone retrieval. Rising diabetic vasculopathy drives vascular-segment growth, aided by handheld Doppler integration. Unified multi-application consoles, such as GE's Versana Premier, allow smaller hospitals to span seven specialties with a single purchase, reducing capex while widening procedure menus.
3D & 4D platforms held 43.95% of the India ultrasound devices market in 2025, favored for obstetric bonding and surgical-planning clarity. The India ultrasound devices market size for these systems benefits from AI plug-ins that shorten fetal-anomaly scans to under 90 seconds. HIFU registers a 3.42% CAGR as non-invasive liver and prostate therapies receive wider reimbursement and specialist training centers multiply. Legacy 2D scanners persist in primary centers where budgets remain tight, while Color Doppler advances in cardiology and peripheral-artery workups. GE HealthCare's USD 51 million Intelligent Ultrasound buyout infused ScanNav Assist into workflow, highlighting competition pivoting to AI-first differentiators.
Portable "other technologies" wrap in smartphone connectivity and edge-AI lesion detection, broadening reach where radiologists are scarce. GE and NVIDIA's self-navigating prototype underpins a future where novice users capture diagnostic-grade imagery, easing the skilled-workforce choke point across the India ultrasound devices market share landscape.